List view / Grid view
20 October 2025 | By
The balance between speed, scale, and compliance has never been more critical. As GLP-1s, biosimilars, and advanced therapies reshape global priorities, pharma leaders face a new question: how can manufacturing infrastructure evolve fast enough to keep pace?
12 December 2016 | By Rosalind Connor, Partner, ARC Pensions Law
Rosalind Connor, a Partner at ARC Pensions Law, warns of the danger of a sustainable R+D industry due to global changes in pension law...
5 December 2016 | By Niamh Louise Marriott, Digital Editor
P is for Psoriasis - the next instalment of our daily pharmaceutical alphabet bringing you up to date with all the latest research...
2 December 2016 | By Niamh Louise Marriott, Digital Editor
O is for Obesity - the next instalment of our daily pharmaceutical alphabet bringing you up to date with all the latest research...
1 December 2016 | By Niamh Louise Marriott, Digital Editor
Embarrassing Bodies' Dr Christian Jessen talks debunking the stigma surround this pandemic disease and explains why it's OK if we don't find a cure...
1 December 2016 | By Niamh Louise Marriott, Digital Editor
N is for Nivolumab - the next instalment of our daily pharmaceutical alphabet bringing you up to date with all the latest research...
30 November 2016 | By Niamh Louise Marriott, Digital Editor
M is for MRSA - the next instalment of our daily pharmaceutical alphabet bringing you up to date with all the latest research...
29 November 2016 | By Niamh Louise Marriott, Digital Editor
L is for Lab Automation - the next instalment of our daily pharmaceutical alphabet bringing you up to date with all the latest research...
28 November 2016 | By Niamh Louise Marriott, Digital Editor
K is for Kidney - the next instalment of our daily pharmaceutical alphabet bringing you up to date with all the latest research...
25 November 2016 | By Niamh Louise Marriott, Digital Content Producer
J is for Joint Pain - the next instalment of our daily pharmaceutical alphabet bringing you up to date with all the latest in this chronic joint pain research...
24 November 2016 | By Niamh Louise Marriott, Digital Content Producer
I is for Immuno-oncology - the next instalment of our daily pharmaceutical alphabet bringing you up to date with all the latest in this cancer research...
23 November 2016 | By Niamh Louise Marriott, Digital Content Producer
H is for Hepatitis C - the next instalment of our daily pharmaceutical alphabet bringing you up to date with all the latest in Hep C research...
22 November 2016 | By Monica McDonnell, Informatica
Informatica's Monica McDonnell gives the lowdown on the Identification of Medicinal Products new regulations and how to manage big data all across Europe...
22 November 2016 | By Niamh Louise Marriott, Digital Content Producer
G is for Gene - the next instalment of our daily pharmaceutical alphabet bringing you up to date with all the latest gene research...
21 November 2016 | By Niamh Louise Marriott, Digital Content Producer
F is for Funding - the next instalment of our daily pharmaceutical alphabet bringing you up to date with all the latest grants and funds...
18 November 2016 | By Niamh Louise Marriott, Digital Content Producer
E is for Epilepsy - the next instalment of our daily pharmaceutical alphabet bringing you up to date with all the latest research on Epilepsy...
